Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins
Abstract
Combined oral contraceptive use is associated with a decreased risk of invasive epithelial ovarian cancer (ovarian cancer). There is suggestive evidence of an inverse association between progestin-only contraceptive use and ovarian cancer risk, but previous studies have been underpowered.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 22, 2021
- Source ID
- 10.1158/1055-9965.epi-20-1355
Entities
People
- Alice W. Lee
- Andrew Berchuck
- Anna H. Wu
- Bhramar Mukherjee
- Celeste Leigh Pearce
- Daniel W. Cramer
- Francesmary Modugno
- Gillian E. Hanley
- Holly R Harris
- Jennifer A Doherty
- Joellen M. Schildkraut
- Karen McLean
- Kathleen Cho
- Kathryn L. Terry
- Kirsten B. Moysich
- Linda Titus
- Malcolm C Pike
- Marc T. Goodman
- Minh Tung Phung
- Penelope M. Webb
- Susan J. Jordan
Organizations
- California State University
- Duke University
- Emory University
- Fred Hutchinson Cancer Center
- Harvard Medical School
- Harvard University
- Memorial Sloan Kettering Cancer Center
- National Center for Research Resources
- National Institutes of Health
- QIMR Berghofer Medical Research Institute
- Roswell Park Comprehensive Cancer Center
- United States Department of Defense
- University of British Columbia
- University of Michigan
- University of Pittsburgh School of Medicine
- University of Southern California
- University of Southern Maine
- University of Utah